Global Alzheimer's Disease Diagnostic Market Research Report 2023

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The global Alzheimer's Disease Diagnostic market was valued at US$ 3680.4 million in 2022 and is anticipated to reach US$ 4024.3 million by 2029, witnessing a CAGR of 1.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Diagnostic.

The Alzheimer's Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alzheimer's Disease Diagnostic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer's Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Genetic Testing

1.2.3 Neurological Exam

1.2.4 Mini-Mental State Exam(MMSE)

1.2.5 Brain Imaging

1.2.6 Other

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Diagnostic Centers

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2018-2029)

2.2 Alzheimer's Disease Diagnostic Growth Trends by Region

2.2.1 Global Alzheimer's Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Alzheimer's Disease Diagnostic Historic Market Size by Region (2018-2023)

2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2024-2029)

2.3 Alzheimer's Disease Diagnostic Market Dynamics

2.3.1 Alzheimer's Disease Diagnostic Industry Trends

2.3.2 Alzheimer's Disease Diagnostic Market Drivers

2.3.3 Alzheimer's Disease Diagnostic Market Challenges

2.3.4 Alzheimer's Disease Diagnostic Market Restraints

3.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue

3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2018-2023)

3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2018-2023)

3.2 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue

3.4 Global Alzheimer's Disease Diagnostic Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2022

3.5 Alzheimer's Disease Diagnostic Key Players Head office and Area Served

3.6 Key Players Alzheimer's Disease Diagnostic Product Solution and Service

3.7 Date of Enter into Alzheimer's Disease Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2018-2023)

4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2024-2029)

5.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Application (2018-2023)

5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2024-2029)

6.1 North America Alzheimer's Disease Diagnostic Market Size (2018-2029)

6.2 North America Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Alzheimer's Disease Diagnostic Market Size by Country (2018-2023)

6.4 North America Alzheimer's Disease Diagnostic Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Alzheimer's Disease Diagnostic Market Size (2018-2029)

7.2 Europe Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Alzheimer's Disease Diagnostic Market Size by Country (2018-2023)

7.4 Europe Alzheimer's Disease Diagnostic Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size (2018-2029)

8.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2018-2023)

8.4 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Alzheimer's Disease Diagnostic Market Size (2018-2029)

9.2 Latin America Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2018-2023)

9.4 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size (2018-2029)

10.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2018-2023)

10.4 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Eli Lilly

11.1.1 Eli Lilly Company Detail

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction

11.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.1.5 Eli Lilly Recent Development

11.2 TauRx

11.2.1 TauRx Company Detail

11.2.2 TauRx Business Overview

11.2.3 TauRx Alzheimer's Disease Diagnostic Introduction

11.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.2.5 TauRx Recent Development

11.3 Alector

11.3.1 Alector Company Detail

11.3.2 Alector Business Overview

11.3.3 Alector Alzheimer's Disease Diagnostic Introduction

11.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.3.5 Alector Recent Development

11.4 Accera

11.4.1 Accera Company Detail

11.4.2 Accera Business Overview

11.4.3 Accera Alzheimer's Disease Diagnostic Introduction

11.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.4.5 Accera Recent Development

11.5 Treventis

11.5.1 Treventis Company Detail

11.5.2 Treventis Business Overview

11.5.3 Treventis Alzheimer's Disease Diagnostic Introduction

11.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.5.5 Treventis Recent Development

11.6 Neuro-Bio

11.6.1 Neuro-Bio Company Detail

11.6.2 Neuro-Bio Business Overview

11.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction

11.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.6.5 Neuro-Bio Recent Development

11.7 Cognition Therapeutics

11.7.1 Cognition Therapeutics Company Detail

11.7.2 Cognition Therapeutics Business Overview

11.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction

11.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2018-2023)

11.7.5 Cognition Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Genetic Testing

    Table 3. Key Players of Neurological Exam

    Table 4. Key Players of Mini-Mental State Exam(MMSE)

    Table 5. Key Players of Brain Imaging

    Table 6. Key Players of Other

    Table 7. Global Alzheimer's Disease Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Alzheimer's Disease Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Alzheimer's Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Alzheimer's Disease Diagnostic Market Share by Region (2018-2023)

    Table 11. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Alzheimer's Disease Diagnostic Market Share by Region (2024-2029)

    Table 13. Alzheimer's Disease Diagnostic Market Trends

    Table 14. Alzheimer's Disease Diagnostic Market Drivers

    Table 15. Alzheimer's Disease Diagnostic Market Challenges

    Table 16. Alzheimer's Disease Diagnostic Market Restraints

    Table 17. Global Alzheimer's Disease Diagnostic Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Alzheimer's Disease Diagnostic Market Share by Players (2018-2023)

    Table 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2022)

    Table 20. Ranking of Global Top Alzheimer's Disease Diagnostic Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnostic Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Alzheimer's Disease Diagnostic Product Solution and Service

    Table 24. Date of Enter into Alzheimer's Disease Diagnostic Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Alzheimer's Disease Diagnostic Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2018-2023)

    Table 28. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2024-2029)

    Table 30. Global Alzheimer's Disease Diagnostic Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2018-2023)

    Table 32. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2024-2029)

    Table 34. North America Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Alzheimer's Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Alzheimer's Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Alzheimer's Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Alzheimer's Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Alzheimer's Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Alzheimer's Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Eli Lilly Company Detail

    Table 50. Eli Lilly Business Overview

    Table 51. Eli Lilly Alzheimer's Disease Diagnostic Product

    Table 52. Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 53. Eli Lilly Recent Development

    Table 54. TauRx Company Detail

    Table 55. TauRx Business Overview

    Table 56. TauRx Alzheimer's Disease Diagnostic Product

    Table 57. TauRx Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 58. TauRx Recent Development

    Table 59. Alector Company Detail

    Table 60. Alector Business Overview

    Table 61. Alector Alzheimer's Disease Diagnostic Product

    Table 62. Alector Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 63. Alector Recent Development

    Table 64. Accera Company Detail

    Table 65. Accera Business Overview

    Table 66. Accera Alzheimer's Disease Diagnostic Product

    Table 67. Accera Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 68. Accera Recent Development

    Table 69. Treventis Company Detail

    Table 70. Treventis Business Overview

    Table 71. Treventis Alzheimer's Disease Diagnostic Product

    Table 72. Treventis Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 73. Treventis Recent Development

    Table 74. Neuro-Bio Company Detail

    Table 75. Neuro-Bio Business Overview

    Table 76. Neuro-Bio Alzheimer's Disease Diagnostic Product

    Table 77. Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 78. Neuro-Bio Recent Development

    Table 79. Cognition Therapeutics Company Detail

    Table 80. Cognition Therapeutics Business Overview

    Table 81. Cognition Therapeutics Alzheimer's Disease Diagnostic Product

    Table 82. Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 83. Cognition Therapeutics Recent Development

    Table 84. Research Programs/Design for This Report

    Table 85. Key Data Information from Secondary Sources

    Table 86. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Alzheimer's Disease Diagnostic Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Alzheimer's Disease Diagnostic Market Share by Type: 2022 VS 2029

    Figure 3. Genetic Testing Features

    Figure 4. Neurological Exam Features

    Figure 5. Mini-Mental State Exam(MMSE) Features

    Figure 6. Brain Imaging Features

    Figure 7. Other Features

    Figure 8. Global Alzheimer's Disease Diagnostic Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Alzheimer's Disease Diagnostic Market Share by Application: 2022 VS 2029

    Figure 10. Clinics Case Studies

    Figure 11. Hospitals Case Studies

    Figure 12. Diagnostic Centers Case Studies

    Figure 13. Other Case Studies

    Figure 14. Alzheimer's Disease Diagnostic Report Years Considered

    Figure 15. Global Alzheimer's Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Alzheimer's Disease Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Alzheimer's Disease Diagnostic Market Share by Region: 2022 VS 2029

    Figure 18. Global Alzheimer's Disease Diagnostic Market Share by Players in 2022

    Figure 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2022

    Figure 21. North America Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Alzheimer's Disease Diagnostic Market Share by Country (2018-2029)

    Figure 23. United States Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Alzheimer's Disease Diagnostic Market Share by Country (2018-2029)

    Figure 27. Germany Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Alzheimer's Disease Diagnostic Market Share by Region (2018-2029)

    Figure 35. China Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Alzheimer's Disease Diagnostic Market Share by Country (2018-2029)

    Figure 43. Mexico Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Alzheimer's Disease Diagnostic Market Share by Country (2018-2029)

    Figure 47. Turkey Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Alzheimer's Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 50. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 51. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 52. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 53. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 54. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 55. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2018-2023)

    Figure 56. Bottom-up and Top-down Approaches for This Report

    Figure 57. Data Triangulation

    Figure 58. Key Executives Interviewed